Cnova Buy Hold or Sell Recommendation

<div class='circular--portrait' style='background:#FF6600;color: #FFFAFA;font-size:4em;padding-top: 25px;;'>CN</div>
CNVAF -- USA Stock  

USD 3.48  0.0034  0.1%

Assuming the 30-days horizon, and your above-average risk tolerance our recommendation regarding Cnova NV is 'Strong Hold'. Macroaxis provides Cnova NV buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding Cnova NV positions. The advice algorithm takes into account all of Cnova NV available fundamental, technical, and predictive indicators you will find on this site. The advice is provided from Cnova NV buy-and-hold perspective. Continue to Cnova NV Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool.

Search Advice


Time Horizon

Risk Tolerance

Execute Advice
Sell Cnova NVBuy Cnova NV
Strong Hold


Hype Condition

Current Valuation

Odds of Distress

Economic Sensitivity

Analyst Consensus

Not Available
For the selected time horizon Cnova NV has a risk adjusted performance of 0.3215, jensen alpha of 0.4382, total risk alpha of 0.2182 and treynor ratio of (1.52)
We provide buy or sell advice to complement the prevailing expert consensus on Cnova NV. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time. To make sure Cnova NV is not overpriced, please confirm all Cnova NV fundamentals, including its gross profit, current ratio, market capitalization, as well as the relationship between the cash and equivalents and earnings per share . Given that Cnova NV has a shares owned by institutions of 0.09 %, we suggest you to validate Cnova NV market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Cnova NV Trading Alerts and Improvement Suggestions

Cnova NV has high likelihood to experience some financial distress in the next 2 years
The company has accumulated 374.13 M in total debt. Cnova NV has a current ratio of 0.55, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due.
The entity reported the revenue of 2.62 B. Net Loss for the year was (112.23 M) with profit before overhead, payroll, taxes, and interest of 389.77 M.
About 99.0% of the company shares are held by company insiders

Cnova NV Returns Distribution Density

The chart of the probability distribution of Cnova NV stock daily returns describes the distribution of returns around its average expected value. We use Cnova NV' stock's Value At Risk and its Upside Potential as a relative measure of the distribution. The distribution of Cnova NV returns is essential to provide solid investment advice for Cnova NV stock.
Mean Return0.41Value At Risk0.00
Potential Upside7.26Standard Deviation2.32
 Return Density 
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Cnova NV historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

Cnova NV Greeks

Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Cnova NV or Cnova NV sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Cnova NV stock's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Cnova stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
Alpha over DOW
Beta against DOW=-0.26
Overall volatility
Information ratio =0.11

Cnova NV Volatility Alert

Cnova NV exhibits very low volatility with skewness of 2.59 and kurtosis of 11.78. However, we advise investors to further study Cnova NV technical indicators to make sure all market info is available and is reliable.
 Better Than Average     
 Worse Than Average Compare Cnova NV to competition

Cnova NV Fundamental Vs Peers

FundamentalsCnova NVPeer Average
Return On Asset0.36 %(0.14) %
Profit Margin(3.01) %(1.27) %
Current Valuation1.2 B16.62 B
Shares Outstanding344.51 M571.82 M
Shares Owned by Insiders98.87 %10.09 %
Shares Owned by Institutions0.09 %39.21 %
Price to Sales0.54 X11.42 X
Revenue2.62 B9.43 B
Gross Profit389.77 M27.38 B
EBITDA11.21 M3.9 B
Net Income(112.23 M)570.98 M
Cash and Equivalents60.94 M2.7 B
Cash per Share0.18 X5.01 X
Total Debt374.13 M5.32 B
Current Ratio0.56 X2.16 X
Book Value Per Share(0.67) X1.93 K
Cash Flow from Operations77.91 M971.22 M
Earnings Per Share(0.34) X3.12 X
Number of Employees218.84 K
Market Capitalization1.22 B19.03 B
Z Score1.88.72

About Cnova NV Buy or Sell Advice

When is the right time to buy or sell Cnova NV? Buying stocks such as Cnova NV isn't very hard. However, what challenging for most investors is doing it at the right time to beat the stock market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily bases. Although Cnova NV investors may find it confusing at the beginning, most of our advising modules are very easy to use and apply. Please read more on our stock advisor page.

Did You Try This Idea?

Run Russia On Wall Street Thematic Idea Now

Russia On Wall Street
Russia On Wall Street Theme
Cross-sector and cross-instrument bundle of publicly traded Russian entities that are expected to be listed on USA exchanges or over the counter. Russia On Wall Street theme has 21 constituents.
View All  Next Launch Russia On Wall Street
Continue to Cnova NV Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments please use Instant Ratings tool. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page